REPORTING: In support of Breast Cancer Awareness Month, the NBA is distributing pink sherpas from Jill Martin’s new clothing line.
This initiative aims to raise awareness about breast cancer and the importance of genetic testing, particularly for those with BRCA gene mutations.Jill Martin, a breast cancer survivor and lifestyle contributor for NBC’s TODAY, has partnered with the NBA and WNBA to create a collection featuring their logos in pink. The campaign kicked off on October 1, with the TODAY Plaza transformed into a pink-themed space, where attendees received the sherpas.All proceeds from the sales of these items will benefit the Basser Center for BRCA, dedicated to research and treatment related to BRCA-related cancers. Martin’s collection includes popular items like sherpa loungers and hoodies, designed to encourage conversations about early testing and prevention.
Jill Martin Teams Up with the NBA and WNBA for Breast Cancer Awareness Collection of Loungers and Hoodies
In recognition of Breast Cancer Awareness Month, Jill Martin has launched a unique collection of loungewear and outerwear featuring the logos of the NBA and WNBA in pink. This initiative aims to promote awareness about breast cancer and the importance of genetic testing, particularly related to BRCA gene mutations.
The collection, part of Martin’s brand “By Jill Martin,” includes popular items such as sherpa loungers and hoodies. To kick off the campaign on October 1, the NBA and WNBA provided pink-logoed sherpas to attendees at the TODAY show, where the event was themed in pink.
All proceeds from this collection will support the Basser Center for BRCA, which focuses on research, treatment, and prevention of BRCA-related cancers. The items are available for purchase through Jill Martin’s official website, Fanatics, select Lids Stores, NBA team stores, and Saks Fifth Avenue, with prices ranging from $89 to $200.
Martin’s mission is deeply personal; she was diagnosed with stage 2 breast cancer in July 2023 after discovering a BRCA2 gene mutation. Following her treatment journey, she is now cancer-free and dedicated to raising awareness about early testing to help others avoid similar challenges.
The message about understanding breast cancer risk holds particular significance for Jill, who was diagnosed with Stage 2 cancer in 2023.Jill discovered she had breast cancer after testing positive for a BRCA gene mutation, despite receiving a clear mammogram on the same day as her diagnosis and a normal sonogram just months earlier. She learned that she inherited the gene mutation from her father, which was unexpected since her family history of breast cancer primarily involved her mother’s side.
